
Sign up to save your podcasts
Or


On this episode of Stock Movers:
- Bayer said an experimental stroke-prevention drug showed positive results in a late-stage study, a boost for the German company as it seeks to counter sales declines from aging blockbuster medicines.
- Hensoldt and other European defense shares are on watch over the latest news around Ukraine
- BHP Group has walked away from a fresh takeover approach for Anglo American Plc, ending an unexpected and short-lived attempt by the world’s largest miner to thwart a planned tie-up between its smaller rival and Canada’s Teck Resources Ltd.
See omnystudio.com/listener for privacy information.
By iHeartPodcasts4.6
1919 ratings
On this episode of Stock Movers:
- Bayer said an experimental stroke-prevention drug showed positive results in a late-stage study, a boost for the German company as it seeks to counter sales declines from aging blockbuster medicines.
- Hensoldt and other European defense shares are on watch over the latest news around Ukraine
- BHP Group has walked away from a fresh takeover approach for Anglo American Plc, ending an unexpected and short-lived attempt by the world’s largest miner to thwart a planned tie-up between its smaller rival and Canada’s Teck Resources Ltd.
See omnystudio.com/listener for privacy information.

404 Listeners

1,170 Listeners

2,201 Listeners

1,967 Listeners

420 Listeners

1,038 Listeners

1,302 Listeners

62 Listeners

59 Listeners

154 Listeners

85 Listeners

80 Listeners

76 Listeners

8 Listeners

11 Listeners